QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,066 signal articles · 542 in last 24h · 103,602 total before filter · latest 11m ago
542last 24h
2521last 7d
483● bullish (7d)
259● bearish (7d)
197publishers
AllMacro247Earnings1481M&A141Regulatory16Product4Analyst30
✕ clear all filtersticker: UNHSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Guardant Health Q2 Earnings Call Highlights
MarketBeat4d agoneutral
Guardant Health Q2 Earnings Call Highlights

Guardant Health (NASDAQ:GH) reported second-quarter 2026 revenue of $335 million, up 44% from a year earlier, as growth accelerated across its oncology, biopharma and data, and screening businesses. The company also raised its full-year revenue outlook, citing demand for its Guardant360 and Shield o

Humana Q2 Earnings Call Highlights
MarketBeat6d agoneutral
Humana Q2 Earnings Call Highlights

Humana (NYSE:HUM) said its 2026 performance is tracking in line with expectations, with management emphasizing planned Medicare Advantage margin expansion in 2027, progress in its Stars program and continued operating-cost reductions as key components of its path toward a sustainable pretax margin o

ENI Q2 Earnings Call Highlights
MarketBeat6d agoneutral
ENI Q2 Earnings Call Highlights

ENI (NYSE:E) reported sharply higher second-quarter and first-half results, citing upstream production growth, favorable market conditions and stronger contributions from its gas, low-carbon and refining-related businesses. Chief Executive Officer Claudio Descalzi said second-quarter pro forma EBIT

Humana Stock Stumbles After Earnings Underwhelm
The Wall Street Journal7d agobearish
Humana Stock Stumbles After Earnings Underwhelm

Humana’s shares dipped in morning trading after its results compared unfavorably with other insurers’ performance this quarter The Medicare-focused insurer modestly beat analysts’ profit projections, offered reassurance on medical cost trends and left guidance unchanged on an adjusted basis.

UnitedHealth’s earnings comeback hides a risk Wall Street can’t price
TheStreet12d agoneutral
UnitedHealth’s earnings comeback hides a risk Wall Street can’t price

UnitedHealth Group (UNH) just delivered the quarter battered shareholders have been waiting for. The health care company blew past Wall Street's profit prediction, increased its most widely monitored cost index, and boosted its full-year earnings outlook. The results seemed to vindicate investors ...

UnitedHealth CFO sends stark warning after earnings
TheStreet17d agoneutral
UnitedHealth CFO sends stark warning after earnings

UnitedHealth Group (UNH) beat Wall Street's numbers on July 16, 2026, but its chief financial officer spent the earnings call making sure nobody mistook that result for a solved cost problem. The company beat earnings estimates by roughly 30%, and management raised full-year guidance well past ...